ANGO

AngioDynamics, Inc. | Healthcare

-1.55902%

Analisi Pre-Earnings (Antonio AI)

2025-12-18
Sentiment
85.0/100
Salute

Caution

Verdict

The narrative is on fire with a recent earnings beat and major product accolades, setting up a perfect pre-earnings squeeze. 🔥 But the books are a black box; I don't touch anything without checking for financial rot first. ⚠️

Catalysts
  • Strong momentum from Q1 revenue beat and reported 26% Med Tech growth.
  • Significant positive PR from NanoKnife® system being named one of TIME's Best Inventions of 2025.
Rischi
  • The company's financial health is completely unknown. High cash burn or a crippling debt load could easily invalidate the positive story.
Approfondisci con Antonio
Valutazione
P/E (TTM)-16.547591750264814
Forward P/E-16.547591750264814
P/S1.757972276351931
Market Cap543407039
Finanze & Debito
CashNone
DebtNone
Debt/Equity0.0
Current Ratio2.294250314870683
Redditività
ROE-0.1748107120440376
Profit Margin-0.10673787402150853
Operating Margin-0.12474145212458183
Rev. Growth-0.1028421972416399
Ultime News (Context per AI)